U.S. Capital Markets Stock News

Crescent Energy upgrade puts earnings expectations in focus Crescent Energy (CRGY) drew fresh attention after being upgraded to a Zacks Rank #1, a move tied to more optimistic earnings expectations that may influence how investors view the stock’s near term risk and reward profile. See our latest analysis for Crescent Energy. The recent Zacks Rank upgrade comes after a period where the stock has cooled in the very short term, with a 30 day share price return down 10.92% and a 7 day share...

BETA Technologies (BETA) is drawing fresh attention after U.S. Transportation Secretary Sean P. Duffy flew in the company’s eVTOL aircraft and helped launch a new FAA pilot program for advanced air mobility testing. See our latest analysis for BETA Technologies. The news flow around BETA has arrived alongside a sharp swing in sentiment, with a 10.21% 7 day share price return and 14.22% 30 day share price return partly offsetting a year to date share price decline of 32.09% from the current...

Lotus Technology Inc. has announced the launch of orders for the Eletre X, a new hybrid SUV available in mainland Europe. The Eletre X features Lotus' proprietary X-Hybrid architecture, which combines battery electric vehicle performance with internal combustion engine support, allowing for a comprehensive range of over 1,200 kilometers. With ultra-fast charging capabilities, the vehicle can charge from 20-80% in just nine minutes, making it one of the quickest charging electrified vehicles...

In recent weeks, AbbVie has secured multiple regulatory wins, including EU approval of AQUIPTA for acute migraine, expanded EU labeling for VENCLYXTO combinations in untreated CLL, and U.S. FDA approval of DECNUPAZ for BPDCN. These moves broaden AbbVie’s neurology and oncology reach into new patient groups, potentially deepening its portfolio beyond its core immunology blockbusters. We’ll now examine how EU approval of AQUIPTA for acute migraine shapes AbbVie’s existing investment narrative...

Recent performance snapshot for CME Group (CME) CME Group (CME) has attracted fresh attention after a stretch of weaker share performance, with the stock down 3% over the past day, 11% over the past week, and 13% over the past month. See our latest analysis for CME Group. At the current share price of US$250.53, CME Group’s recent 30 day share price return has weakened alongside a softer 90 day move, even though the 3 year and 5 year total shareholder returns remain firmly positive. If you...

Arm Holdings (NasdaqGS:ARM) is back in the spotlight after signing ByteDance, Oracle, and Meta Platforms as AGI CPU customers, while Nvidia’s new RTX Spark chip on Arm architecture highlights AI infrastructure demand. See our latest analysis for Arm Holdings. Arm’s latest AGI CPU wins and the RTX Spark launch come on top of a powerful run, with a 30 day share price return of 90.70% and a year to date share price return of 251.01%. The 1 year total shareholder return of 212.71% highlights how...

Investors may be wondering whether Fluence Energy's current share price reflects its true worth, or if the recent buzz has pushed it out of line with fundamentals. The stock last closed at US$27.91, with returns of 30.8% over 7 days, 129.0% over 30 days, 21.3% year to date and a very large 1 year return of 485.1% that may have changed how the market views its potential and risk. Recent headlines around Fluence Energy have focused on its role in energy storage solutions and its position...

Media spotlight and defense contract put Swarmer in focus Investor attention around Swarmer (SWMR) has picked up after Jim Cramer highlighted the military drone company on CNBC and the stock moved sharply, coinciding with news of a new U.S. defense contract. See our latest analysis for Swarmer. The recent CNBC spotlight and fresh U.S. defense contract arrive on top of very strong recent momentum, with a 1-day share price return of 37.7%, a 7-day share price return of 77.4%, a 30-day share...

Morgan Stanley recently expanded its fixed‑income funding with new callable global medium‑term notes, including 4.21% Notes due July 6, 2027 and 4.25% Senior Unsecured Notes due August 4, 2027, while also leading a US$33 million growth financing for AI imaging firm Subtle Medical. Alongside these balance‑sheet and private‑market moves, the bank is broadening its product toolkit with a spot Bitcoin ETF and complex market‑linked securities, underscoring how it is repositioning around...

Figma stock performance snapshot Figma (FIG) has recently drawn investor attention after a period of mixed share performance, including a 10.4% single day decline and a 29.6% gain over the past month, alongside a year to date decline of 35.4%. See our latest analysis for Figma. At a share price of US$24.29, the stock has swung sharply in recent weeks. It has a 1 month share price return of 29.6%, but a year to date share price return that is down 35.4%. This points to momentum recovering...

Novo Nordisk (NYSE:NVO) is set to present new clinical data from its cardiometabolic portfolio at the 2026 American Diabetes Association Scientific Sessions. Key updates include Phase 3 REIMAGINE trial results for CagriSema and new real-world evidence for weight-loss drug Wegovy. The data will focus on blood sugar control and weight reduction outcomes across different patient populations. For investors watching NYSE:NVO, this scientific update arrives after a period of share price pressure...

In late May 2026, Mercury Systems announced it had secured a multi-year contract to deliver 1,000 RTBX06 BuiltSECURE servers to Blue Raven, while also collaborating with Altera and VadaTech to extend Agilex 9 FPGA-based solutions for defense customers. This is Mercury’s largest single RTBX06 order to date and pairs with deeper FPGA ecosystem partnerships, underscoring its role in secure, high-performance processing for mission-critical defense applications. We’ll now examine how this record...

Portland General Electric recently filed a supplemental Recreation Resources Management Plan with federal regulators for its Clackamas River hydro project, while partner Avangrid connected the 166 MW Tower Solar facility to PGE’s grid ahead of expected commercial operation later this year. Together with Oregon’s approval of a new large-load tariff framework for data centers above 20 MW, these steps highlight how PGE is pairing cleaner generation with tailored pricing to meet power-intensive...

Iovance Biotherapeutics recently received FDA clearance for its IND application to begin a Phase 1/2 trial of IOV-5001, a next-generation IL-12 tethered tumor infiltrating lymphocyte therapy for advanced solid tumors including colorectal and certain breast cancers. This program aims to localize IL-12 expression within tumors via tethered TIL cells, seeking to enhance anti-tumor activity while limiting systemic toxicity, which could be important for broad solid-tumor use. We’ll now examine...

Recent performance context for Tower Semiconductor Tower Semiconductor (TSEM) has caught investor attention after a strong recent run, with the stock up about 26% over the past month and showing a very large gain over the past 3 months. See our latest analysis for Tower Semiconductor. That surge has come after a very large 3 month share price return of about 122%, while the 1 year total shareholder return is close to 7x, pointing to powerful momentum and a sharp reassessment of Tower...

If you are wondering whether First Busey at US$27.43 still offers value, it is important to understand how its current share price compares with a range of valuation checks. The stock is up 26.0% over the past year and 14.8% year to date, with a more modest 3.1% gain over 30 days and a slight 0.5% decline over the last week. This may prompt you to ask whether the recent run still leaves any margin of safety. Recent coverage has focused on First Busey as part of the broader US regional banks...

If you are wondering whether Best Buy stock at around US$72.78 is offering good value right now, the key is to look past the headline price and focus on what the numbers suggest about its valuation. The stock has recently shown strong price moves, with returns of 15.1% over 7 days, 21.2% over 30 days, 5.2% year to date, and 10.1% over 1 year. These changes can influence how investors think about both potential and risk. These moves are set against ongoing interest in big ticket consumer...

Recent share performance and business snapshot BILL Holdings (BILL) has drawn investor attention after a period where the stock is down about 24% year to date, despite reporting US$1.6b in revenue and US$163 million in net income. The company runs a financial operations platform for small and midsize businesses, offering cloud-based payments, accounts payable and receivable automation, and spend management tools that aim to streamline back-office workflows. See our latest analysis for...

Rising Treasury yields are pressuring the traditional safe haven status of utilities, including Vistra (NYSE:VST). Vistra is taking on large acquisitions and capital projects to serve fast growing electricity demand from AI and data centers. Execution, climate liability exposure, and commodity price volatility are becoming more central to the risk profile for Vistra and its peers. For Vistra, this shift comes at a time when the stock trades around $157.97 and sits on very large multi year...

Aeropay recently announced it is using Jack Henry’s embedded payments technology, integrating Jack Henry Payments Orchestrator to enhance instant, multi-rail pay-by-bank capabilities across its national network. This collaboration underscores Jack Henry’s role as a core infrastructure provider for real-time, account-to-account payments, where orchestration, uptime, and risk intelligence are increasingly central to how merchants and platforms accept bank-based payments. We’ll now examine how...

If you are wondering whether Mueller Water Products at US$25.08 is offering good value today, it helps to step back and look at what the recent share performance and fundamentals are really telling you. The stock is up 3.3% over the past year and 4.8% year to date, even though it has fallen 2.7% over the last week and 8.4% over the last month. This may have changed how the market views its upside and risk. Recent coverage has focused on Mueller Water Products' position within the capital...

Recent share performance and business snapshot Mattel (MAT) shares have been under pressure, with the stock down 3% over the past month and 9% over the past 3 months, as investors reassess the toymaker’s recent financial profile. The company generates US$5.38b in annual revenue and US$498.93m in net income, with operations spread across North America and international markets, including Europe, the Middle East, Africa, Latin America, and the Asia Pacific. See our latest analysis for...

In late May 2026, CoreWeave announced it had become the first AI cloud provider to stand up, fully validate, and operate NVIDIA’s Vera Rubin NVL72 rack-scale system on its cloud, integrating custom liquid cooling, rack control, and networking to unlock the platform’s advanced agentic AI capabilities. An interesting angle is that this Vera Rubin deployment relies on CoreWeave-built software-defined cooling and unified rack management, effectively turning each NVIDIA rack into a standardized...

Dycom Industries recently reported first‑quarter 2026 results with contract revenues of US$1,964.78 million and net income of US$91.29 million, raised its full‑year fiscal 2027 revenue outlook to US$7.38–US$7.65 billion, continued executing its share buyback program, and saw two directors retire under its tenure policy, reducing the board to nine members. Beyond the headline earnings beat, Dycom’s willingness to lift revenue guidance while maintaining capital returns through buybacks...